References
Kawabata H, Usuki K, Shindo-Ueda M, Kanda J, Tohyama K, Matsuda A, et al. Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes. Int J Hematol. 2019;110:533–42.
Pileggi C, Di Sanzo H, Mascaro V, Marafioti MG, Costanzo FS, Pavia M. Role of serum ferritin level on overall survival in patients with myelodysplastic syndromes: Results of a meta-analysis of observational studies. PLoS ONE. 2017;12:e0179016.
Park S, Sapena R, Kelaidi C, Vassilieff D, Bordessoule D, Stamatoullas A, et al. Ferritin level at diagnosis is not correlated with poorer survival in non-RBC transfusion dependent lower risk de novo MDS. Leuk Res. 2011;35:1530–3.
Acknowledgements
This study was conducted with partial support from National Council for Scientific and Technological Development (CNPq).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Mota, A.G.M., da Silva Mendonça, P., Ribeiro Junior, H.L. et al. Do small increases in serum ferritin impact prognosis in lower-risk MDS patients?. Int J Hematol 111, 742–744 (2020). https://doi.org/10.1007/s12185-020-02848-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-020-02848-3